Xia Zhou

机构：Qingdao University, Dalian University of Technology, Southwest Medical University, Affiliated Hospital of Qingdao University · ORCID：0000-0003-2024-1066

发表论文 32 篇 · 总被引 577 次 · h-index 10

代表论文

• DHODH and cancer: promising prospects to be explored (2021 · Cancer & Metabolism · 被引 182)
• Bifunctional Naphtho[2,3-d][1,2,3]triazole-4,9-dione Compounds Exhibit Antitumor Effects In Vitro and In Vivo by Inhibiting Dihydroorotate Dehydrogenase and Inducing Reactive Oxygen Species Production (2020 · Journal of Medicinal Chemistry · 被引 53)
• Identification and Preclinical Pharmacology of BMS-986104: A Differentiated S1P 1 Receptor Modulator in Clinical Trials (2016 · ACS Medicinal Chemistry Letters · 被引 32)
• Biophysical and biochemical properties of PHGDH revealed by studies on PHGDH inhibitors (2021 · Cellular and Molecular Life Sciences · 被引 22)
• Identification and Preclinical Pharmacology of ((1R,3S)-1-Amino-3-((S)-6-(2-methoxyphenethyl)-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol (BMS-986166): A Differentiated Sphingosine-1-phosphate Receptor 1 (S1P1) Modulator Advanced into Clinical Trials (2019 · Journal of Medicinal Chemistry · 被引 21)
• The novel LSD1 inhibitor ZY0511 suppresses diffuse large B-cell lymphoma proliferation by inducing apoptosis and autophagy (2021 · Medical Oncology · 被引 20)